EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Translating Metabolic Interventions into Breast Cancer Therapy: A Comprehensive Review

Luxi Chen iD, Stephen L Shiao, Yuan Yuan iD

Life · 20.10.2025 · 15 (10) · 1634

DOI: 10.3390/life15101634 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 20.10.2025. Verfasst von Luxi Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cedars-Sinai Cancer Developmental Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer remains a leading cause of morbidity and mortality in women worldwide. Despite significant advances in targeted therapies, therapeutic resistance, metabolic toxicities, and disease recurrence continue to limit long-term efficacy. Metabolic syndrome is a major epidemiologic risk factor for the development of breast cancer, with metabolic dysregulation strongly linked to tumor progression, recurrence, and mortality. Crosstalk between insulin and insulin-like growth factor (IGF) signaling and oncogenic pathways such as PI3K/AKT/mTOR provides a mechanistic basis for these associations, highlighting the interplay between metabolism and tumor biology. Given this context, anti-diabetic and anti-obesity agents are being investigated as novel therapeutic strategies in breast cancer. Beyond their established metabolic benefits, these agents can directly modulate tumor cell growth, immune responses, and signaling pathways central to breast cancer pathogenesis. In this review, we summarize the current knowledge on the intersection of metabolic dysregulation and breast cancer as well as critically evaluate preclinical and clinical evidence supporting the use of metabolic therapies in this space.

Schlagwörter

Stichwörter der Autor:innen

breast cancercancer therapiesmetabolic syndromesignaling pathwaystumor microenvironment

Autor:innen und Institutionen

  • Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

ORCID-Profile: Luxi Chen, Yuan Yuan

Förderung

  • Cedars-Sinai Cancer Developmental Funds

Zitieren

APA

Chen, L., Shiao, S. L., & Yuan, Y. (2025). Translating Metabolic Interventions into Breast Cancer Therapy: A Comprehensive Review. Life, 15(10), 1634. https://doi.org/10.3390/life15101634

Vancouver

Chen L, Shiao SL, Yuan Y. Translating Metabolic Interventions into Breast Cancer Therapy: A Comprehensive Review. Life. 2025;15(10):1634. doi:10.3390/life15101634

BibTeX
@article{Chen2025,
  author = {Chen, Luxi and Shiao, Stephen L and Yuan, Yuan},
  title = {Translating Metabolic Interventions into Breast Cancer Therapy: A Comprehensive Review},
  journal = {Life},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {1634},
  doi = {10.3390/life15101634}
}
Kostenlos starten →